Kymera Therapeutics, Inc. (KYMR)

80.69 -0.38 (-0.47%) USD  |  NASDAQ  |  May 01, 16:00
80.69 0.00 (0.00%) After-Hours: 20:00
More

Kymera Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade